FK506 binding protein (BP) 12, an immunophilin of FK506-binding protei
ns, is involved in intra-cellular signal transduction through the calc
ineurin-nuclear factor pathway. FKBP12 is reported to be associated wi
th the ryanodine-receptor and IP3 Ca2+ channels, and to regulate cell
proliferation via binding transforming growth factor (TGF)-beta recept
or and cyclin dependent kinase (CDK). To elucidate the function of FKB
P12 in cardiac development, we analyzed the temporal profile and regul
ation of FKBP12 expression in chick heart and in cultured cardiomyocyt
es. FKBP12 is expressed in embryos as early as day 4 and is predominan
tly associated with cardiomyocytes and osteo-chondrocytes. Tissue FKBP
level in the heart increases with development. Immunohistochemically,
the distribution and levels of FKBP12 appear to be related to sarco-e
ndoplasmic reticulum Ca-ATPase 2 (SERCA2) but not to sarcomeric protei
ns. In proliferating cells, FKBP12 expression correlates with cellular
mitosis, but not with DNA synthesis. In earlier embryos (<day 8), sup
pressing the activity of FKBP by FK506 administration is lethal, and i
nduces cardiomegaly at later stages. In cultured cardiomyocytes, FK506
reduces the level of contractile proteins and inhibits cell prolifera
tion. These results show that FKBP12 is enriched in cell types involve
d in dynamic Ca handling, and is likely an important molecule for card
iac development. FKBP12 most likely functions by affecting cellular Ca
handling, since its effects are modified by modulators of Ca handling
by sarcoplasmic reticulum.